Epigenomics AG / Key word(s): MiscellaneousU.S. Centers for Medicare & Medicaid Services publish negative NCD for Epi proColon 20-Jan-2021 / 00:02 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of […]
Category: Insider Information
19. January 2021
U.S. Centers for Medicare & Medicaid Services publish negative NCD for Epi proColon
Read more
07. January 2021
Epigenomics AG issues mandatory convertible bond in the amount of up to EUR 5.5 million
Epigenomics AG / Key word(s): Issue of Debt/BondEpigenomics AG issues mandatory convertible bond in the amount of up to EUR 5.5 million 07-Jan-2021 / 09:36 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible […]
03. November 2020
Epigenomics AG: Capital reduction and further authorization to issue convertible bonds with backstop investor planned
Epigenomics AG / Key word(s): Corporate Action/AGM/EGMEpigenomics AG: Capital reduction and further authorization to issue convertible bonds with backstop investor planned 03-Nov-2020 / 11:48 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for […]
16. October 2020
Epigenomics AG: U.S. Centers for Medicare & Medicaid Services publish negative proposed NCD for Epi proColon
Epigenomics AG / Key word(s): MiscellaneousEpigenomics AG: U.S. Centers for Medicare & Medicaid Services publish negative proposed NCD for Epi proColon 17-Oct-2020 / 00:03 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for […]
31. March 2020
Epigenomics AG successfully completes capital increase
Epigenomics AG / Key word(s): Capital IncreaseEpigenomics AG successfully completes capital increase 31-March-2020 / 09:02 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. NOT FOR PUBLICATION, DISTRIBUTION […]
30. March 2020
Epigenomics AG decides to increase share capital by way of private placement
Epigenomics AG / Key word(s): Capital Increase/Corporate ActionEpigenomics AG decides to increase share capital by way of private placement 30-March-2020 / 19:53 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content […]